Outpatient Treatment for Cutaneous Leishmaniasis in Children

109 3

Clinical Message


There are a number of nonpainful treatment options available to treat CL in young children. Miltefosine is the only therapy investigated in a purely paediatric population, and it has been shown to be noninferior and possibly superior to antimony treatment. Topical paromomycin has been shown to be more effective than placebo. Both can be administered without the need for costly inpatient admission and both are more suitable than intralesional antimony, which can be very painful. Both of these treatment options are currently unlicensed in the U.K. for the treatment of cutaneous leishmaniasis.

Subscribe to our newsletter
Sign up here to get the latest news, updates and special offers delivered directly to your inbox.
You can unsubscribe at any time

Leave A Reply

Your email address will not be published.